#ASGCT21 is available on demand until August 13!
Access the Meeting Platform

OBiO Technology

Shanghai,  Shanghai 

Gene Medicine | Made in China | By OBiO

OBiO Technology is a biopharmaceutical company founded in 2013. We have built a gene therapy product manufacturing platform that meets NMPA, FDA, and EMA cGMP standards. Our CDMO platform offers plasmid, AAV, lentivirus, adenovirus, oncolytic viruses, and cell therapy cGMP manufacturing service, to scientists and pharmaceutical companies in the global GCT field. From 2020, we have initiated the construction of the 80,000 m2 cGMP manufacturing plants in Lin-Gang, Shanghai to satisfy the explosively growing global demand, striving to become a leading gene therapy CDMO in the world.

Brands: OBiO